Tilray Brands, Inc.
TLRY evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for TLRY—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Financial data as of Feb 28, 2026.
Run Tilray Brands, Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Tilray Brands, Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
50.4 months
D/E 0.35
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 1 sell (180d)
Runway
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
210
Total value held
$120.8M
| Holder | Shares | Value |
|---|---|---|
| susquehanna international group, llp | 9,239,532 | $59.8M |
| citadel advisors llc | 1,621,988 | $10.5M |
| jane street group, llc | 655,845 | $4.2M |
| morgan stanley | 641,025 | $4.1M |
| mirae asset global etfs holdings ltd. | 486,820 | $3.1M |
| aqr capital management llc | 447,588 | $2.9M |
| blackrock, inc. | 422,898 | $2.7M |
| walleye trading llc | 400,200 | $2.6M |
| vanguard portfolio management llc | 348,928 | $2.3M |
| state street corp | 248,000 | $1.6M |
Showing top 10 of 210 institutional holders of Tilray Brands, Inc.. Open the full 13F history after sign-in.
Short Interest
as of Apr 21, 2026- % of float
- 12.3%
- Days to cover
- 5.6
- Shares short
- 14,250,227
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
TLRY short interestGovernance
Frequently asked questions
Who is the CEO of Tilray Brands, Inc.?
Mr. Irwin David Simon is the chief executive officer of Tilray Brands, Inc. (TLRY).
Where is Tilray Brands, Inc. headquartered?
Tilray Brands, Inc. (TLRY) is headquartered in Leamington, ON, Canada.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.